4.7 Article

Response to interferons and antibacterial innate immunity in the absence of tyrosine-phosphorylated STAT1

期刊

EMBO REPORTS
卷 17, 期 3, 页码 367-382

出版社

WILEY
DOI: 10.15252/embr.201540726

关键词

innate immunity; interferon; pathogen; phosphorylation; STAT1

资金

  1. Austrian Science Fund (FWF) [SFB-28]
  2. FWF

向作者/读者索取更多资源

Signal transducer and activator of transcription 1 (STAT1) plays a pivotal role in the innate immune system by directing the transcriptional response to interferons (IFNs). STAT1 is activated by Janus kinase (JAK)-mediated phosphorylation of Y701. To determine whether STAT1 contributes to cellular responses without this phosphorylation event, we generated mice with Y701 mutated to a phenylalanine (Stat1Y701F). We show that heterozygous mice do not exhibit a dominant-negative phenotype. Homozygous Stat1Y701F mice show a profound reduction in Stat1 expression, highlighting an important role for basal IFN-dependent signaling. The rapid transcriptional response to type I IFN (IFN-I) and type II IFN (IFNc) was absent in Stat1Y701F cells. Intriguingly, STAT1Y701F suppresses the delayed expression of IFN-I-stimulated genes (ISG) observed in Stat1(-/-) cells, mediated by the STAT2/IRF9 complex. Thus, Stat1Y701F macrophages are more susceptible to Legionella pneumophila infection than Stat1(-/-) macrophages. Listeria monocytogenes grew less robustly in Stat1Y701F macrophages and mice compared to Stat1(-/-) counterparts, but STAT1Y701F is not sufficient to rescue the animals. Our studies are consistent with a potential contribution of Y701-unphosphorylated STAT1 to innate antibacterial immunity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection

Prachi Bagadia, Kevin W. O'Connor, Renee Wu, Stephen T. Ferris, Jeffrey P. Ward, Robert D. Schreiber, Theresa L. Murphy, Kenneth M. Murphy

Summary: Bcl6 is required for the development of a subset of cDC1-specific markers in vitro but not in vivo. Its deficiency selectively reduces CD8 alpha expression in cDC1 without affecting XCR1 or CD24 expression.

JOURNAL OF IMMUNOLOGY (2021)

Article Biochemical Research Methods

Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage

Priyank Shukla, Preeti Pandey, Bodhayan Prasad, Tony Robinson, Rituraj Purohit, Leon G. D'Cruz, Murtaza M. Tambuwala, Ankur Mutreja, Jim Harkin, Taranjit Singh Rai, Elaine K. Murray, David S. Gibson, Anthony J. Bjourson

Summary: This study utilizes immuno-informatics tools and bioinformatics databases to identify potential immunogenic epitopes of SARS-CoV-2 and validates their binding and interaction with HLA proteins. These findings have significant implications for the development of globally effective SARS-CoV-2 vaccines.

BRIEFINGS IN BIOINFORMATICS (2022)

Article Hematology

Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade

Katharina Woess, Sabine Macho-Maschler, Dorette S. van Ingen Schenau, Miriam Butler, Caroline Lassnig, Daniel Valcanover, Andrea Poelzl, Katrin Meissl, Barbara Maurer, Tania Brandstoetter, Claus Vogl, Anna Koren, Stefan Kubicek, Anna Orlova, Richard Moriggl, Birgit Strobl, Veronika Sexl, Frank N. van Leeuwen, Roland P. Kuiper, Mathias Muelle

Summary: TYK2 mutations can cause leukemia, and this study shows that TYK2 inhibitors combined with mTOR or CDK4/6 inhibitors can be a potential treatment for TYK2-driven acute leukemia.

HAEMATOLOGICA (2023)

Editorial Material Oncology

A New Year, A New Initiative

Robert D. Schreiber, Philip D. Greenberg

Summary: Looking back at 2021, the challenges brought by the COVID-19 pandemic highlighted the importance of scientific research and collaboration. Cancer Immunology Research plays a central role in this rapidly growing field. The Journal received a record number of original research articles and achieved a high Impact Factor in 2021. The success of Cancer Immunology Research is attributed to the hard work of many individuals, including editors, reviewers, and researchers. The Journal remains committed to publishing innovative research and advancing cancer immunology and immunotherapy education.

CANCER IMMUNOLOGY RESEARCH (2022)

Article Multidisciplinary Sciences

PTPN2 elicits cell autonomous and non-cell autonomous effects on antitumor immunity in triple-negative breast cancer

Pei Kee Goh, Florian Wiede, Mara N. Zeissig, Kara L. Britt, Shuwei Liang, Tim Molloy, Nathan Goode, Rachel Xu, Sherene Loi, Mathias Muller, Patrick O. Humbert, Catriona McLean, Tony Tiganis

Summary: The tumor-suppressor gene PTPN2 is often diminished in a specific type of breast cancer. Surprisingly, the absence of PTPN2 in tumors or T cells can actually promote the recruitment and activation of T cells, leading to enhanced anti-tumor immunity. Targeting PTPN2 in tumor cells and T cells has therapeutic potential, as PTPN2 deficiency is associated with T cell infiltration and increased expression of PD-L1 in triple-negative breast cancers (TNBCs). Furthermore, deleting PTPN2 in mouse TNBC models can enhance T cell recruitment and PD-L1 expression, leading to suppressed tumor growth and improved efficacy of anti-PD-1 treatment. Additionally, deleting PTPN2 in both tumors and T cells can further facilitate T cell recruitment and activation, resulting in repression of tumor growth or even elimination of tumors dominated by exhausted T cells. Therefore, targeting PTPN2 in tumors and/or T cells can enhance T cell recruitment and alleviate inhibitory effects on T cells to combat TNBC.

SCIENCE ADVANCES (2022)

Article Oncology

cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1

Stephen T. Ferris, Ray A. Ohara, Feiya Ou, Renee Wu, Xiao Huang, Sunkyung Kim, Jing Chen, Tian-Tian Liu, Robert D. Schreiber, Theresa L. Murphy, Kenneth M. Murphy

Summary: It has been found that dendritic cells (DC) do not directly activate tumor-specific T cells, but induce anti-tumor immune responses by transferring their antigens to host DCs. Type 1 conventional DCs (cDC1) are more effective than GMDC as cancer vaccines. Vaccination with cDC1 can activate tumor-specific CD8+ T cells and lead to tumor rejection.

CANCER IMMUNOLOGY RESEARCH (2022)

Article Multidisciplinary Sciences

Interferons reshape the 3D conformation and accessibility of macrophage chromatin

Ekaterini Platanitis, Stephan Gruener, Aarathy Ravi Sundar Jose Geetha, Laura Boccuni, Alexander Vogt, Maria Novatchkova, Andreas Sommer, Iros Barozzi, Mathias Mueller, Thomas Decker

Summary: This study investigates the role of macrophages in innate immune responses and reveals that interferons trigger significant changes in cellular transcriptomes through JAK-STAT signal transduction and STAT transcription factors. Additionally, it shows that interferons cause rearrangement of chromatin structure and increased DNA accessibility, highlighting the importance of three-dimensional nuclear space and epigenome in transcriptional control by the IFN-induced JAK-STAT pathway.

ISCIENCE (2022)

Article Biochemical Research Methods

ATRPred: A machine learning based tool for clinical decision making of anti-TNF treatment in rheumatoid arthritis patients

Bodhayan Prasad, Cathy McGeough, Amanda J. Eakin, Tan S. Ahmed, Dawn Small, Philip Gardiner, Adrian Pendleton, Gary Wright, Anthony Bjourson, David Gibson, Priyank Shukla

Summary: This study examines the plasma protein profiles of rheumatoid arthritis (RA) patients and identifies two molecular subgroups. A machine learning-based classifier called ATRPred is developed to predict the response to anti-TNF treatment in RA patients with 81% accuracy. This research helps optimize treatment selection and improve the life quality of non-responsive RA patients.

PLOS COMPUTATIONAL BIOLOGY (2022)

Article Biochemical Research Methods

Data-driven patient stratification of UK Biobank cohort suggests five endotypes of multimorbidity

Bodhayan Prasad, Anthony J. Bjourson, Priyank Shukla

Summary: Multimorbidity refers to the concurrent occurrence of multiple chronic conditions. This study developed a pipeline that can stratify patients into different subgroups based on their disease diagnosis and demographic features. The researchers identified five distinct endotypes of multimorbidity using this pipeline and validated their accuracy using machine learning. The study highlights the importance of dementia, stroke, and paralysis as drivers of multimorbidity stratification. The findings suggest that including patient stratification at the primary care setting can improve the observation and treatment of multiple chronic conditions.

BRIEFINGS IN BIOINFORMATICS (2022)

Article Biochemical Research Methods

muSignAl: An algorithm to search for multiple omic signatures with similar predictive performance

Bodhayan Prasad, Anthony J. Bjourson, Priyank Shukla

Summary: We have developed an algorithm called muSignAl that selects multiple signatures with similar predictive performance for multidimensional omic datasets. This algorithm bypasses the need to explore all feature combinations, addressing the limitations of low sample size and high computational cost.

PROTEOMICS (2023)

Article Oncology

Tyk2 is a tumor suppressor in colorectal cancer

Stefan Moritsch, Bernadette Moedl, Irene Scharf, Lukas Janker, Daniela Zwolanek, Gerald Timelthaler, Emilio Casanova, Maria Sibilia, Thomas Mohr, Lukas Kenner, Dietmar Herndler-Brandstetter, Christopher Gerner, Mathias Mueller, Birgit Strobl, Robert Eferl

Summary: This study investigates the role of Janus kinase Tyk2 in solid tumors and suggests its tumor-suppressive functions in immune cells and epithelial cancer cells. It also reveals the different immune editing patterns and regulation of immune checkpoint genes in Tyk2-deficient tumors, highlighting the importance of Tyk2 in colorectal cancer progression and immune surveillance.

ONCOIMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Stress signaling boosts interferon-induced gene transcription in macrophages

Laura Boccuni, Elke Podgorschek, Moritz Schmiedeberg, Ekaterini Platanitis, Peter Traxler, Philipp Fischer, Alessia Schirripa, Philipp Novoszel, Angel R. Nebreda, J. Simon C. Arthur, Nikolaus Fortelny, Matthias Farlik, Veronika Sexl, Christoph Bock, Maria Sibilia, Pavel Kovarik, Mathias Mueller, Thomas Decker

Summary: This study reveals the synergistic effect of cell stress-induced p38 MAPK signaling and IFN-stimulated signal transduction, and the impact of this synergy on ISG expression and macrophage infection ability.

SCIENCE SIGNALING (2022)

Article Hematology

Duodenal macrophages control dietary iron absorption via local degradation of transferrin

Nyamdelger Sukhbaatar, Maria Schoeller, Stephanie Deborah Fritsch, Monika Linke, Stefanie Horer, Manuela Traeger, Mario Mazic, Stephan Forisch, Karine Gonzales, Jan Pascal Kahler, Carina Binder, Caroline Lassnig, Birgit Strobl, Mathias Mueller, Barbara Scheiber-Mojdehkar, Claudia Gundacker, Stefanie Dabsch, Renate Kain, Markus Hengstschlaeger, Steven H. L. Verhelst, Guenter Weiss, Igor Theurl, Thomas Weichhart

Summary: Iron is a crucial cellular metal for various physiological functions. Its absorption from the diet and transport by transferrin is important for iron metabolism. Regulation of iron absorption and transfer remains poorly understood. In this study, macrophage-specific deletion of Tsc2, a negative regulator of mTORC1, in mice led to defects in iron metabolism, including impaired erythropoiesis and reduced Tf saturation. This was due to an iron import block in the duodenal epithelial cells. Activation of mTORC1 in duodenal macrophages promoted Tf degradation, while depletion of macrophages increased Tf levels. Inhibition of mTORC1 or serine protease activity restored Tf levels in the Tsc2-deficient mice. These findings suggest that duodenal macrophages regulate iron transfer by controlling Tf availability.
Article Multidisciplinary Sciences

Inducible overexpression of a FAM3C/ILEI transgene has pleiotropic effects with shortened life span, liver fibrosis and anemia in mice

Ulrike Schmidt, Betuel Uluca, Iva Vokic, Barizah Malik, Thomas Kolbe, Caroline Lassnig, Martin Holcmann, Veronica Moreno-Viedma, Bernhard Robl, Carina Muehlberger, Dagmar Gotthardt, Maria Sibilia, Thomas Ruelicke, Mathias Mueller, Agnes Csiszar

Summary: FAM3C/ILEI is an important factor in epithelial-to-mesenchymal transition (EMT) induction, tumor progression, and metastasis. In this study, the researchers generated a new Tet-ON inducible Fam3c/ILEI transgenic mouse strain, providing a versatile tool to model the effect of elevated ILEI expression in various tissue entities and disease conditions, including cancer.

PLOS ONE (2023)

Article Endocrinology & Metabolism

Simvastatin is associated with superior lipid and glycaemic control to atorvastatin and reduced levels of incident Type 2 diabetes, in men and women, in the UK Biobank

Andrew R. English, Bodhayan Prasad, Declan H. McGuigan, Geraldine Horigan, Maurice O'Kane, Anthony J. Bjourson, Priyank Shukla, Catriona Kelly, Paula L. McClean

Summary: This study compares the effects of simvastatin and atorvastatin on lipid and glycaemic control in men and women with and without T2DM. The research findings suggest that simvastatin provides better lipid and glycaemic control than atorvastatin, with a reduced risk of incident T2DM, in both genders. The results may help guide prescribing practices for better management of T2DM and its complications.

ENDOCRINOLOGY DIABETES & METABOLISM (2022)

暂无数据